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Although data describe the presence and increase of inflammatory mediators in the
local environment in periodontitis vs. health in humans, details regarding how these
responses evolve in the transition from health to disease, changes during disease
progression, and features of a resolved lesion remain unknown. This study used a
nonhuman primate model of ligature-induced periodontitis in young, adolescent, adult,
and aged animals to document features of inflammatory response affected by age.
Rhesus monkeys had ligatures tied and provided gingival tissue biopsy specimens at
baseline, 0.5, 1, and 3 months of disease and at 5 months of the study, which was
2 months post-ligature removal for clinically resolved tissues. The transcriptome was
assessed using microarrays for chemokine (n = 41), cytokine (n = 45), chemokine
receptor (n = 21), cytokine receptor (n = 37), and lipid mediator (n = 31) genes. Limited
differences were noted in healthy tissues for chemokine expression with age; however,
chemokine receptor genes were decreased in young but elevated in aged samples.
IL1A, IL36A, and IL36G cytokines were decreased in the younger groups, with IL36A
elevated in aged animals. IL10RA/IL10RB cytokine receptors were altered with age.
Striking variation in the lipid mediator genes in health was observed with nearly 60% of
these genes altered with age. A specific repertoire of chemokine and chemokine receptor
genes was affected by the disease process, predominated by changes during disease
initiation. Cytokine/cytokine receptor genes were also elevated with disease initiation,
albeit IL36B, IL36G, and IL36RN were all significantly decreased throughout disease
and resolution. Significant changes were observed in similar lipid mediator genes with
disease and resolution across the age groups. Examination of the microbiome links to
the inflammatory genes demonstrated that specific microbes, including Fusobacterium,
P. gingivalis, F. alocis, Pasteurellaceae, and Prevotella are most frequently significantly
correlated. These correlations were generally positive in older animals and negative in
younger specimens. Gene expression and microbiome patterns from baseline were
distinctly different from disease and resolution. These results demonstrate patterns of
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inflammatory gene expression throughout the phases of the induction of a periodontal
disease lesion. The patterns show a very different relationship to specific members of the
oral microbiome in younger compared with older animals.
Keywords: non-human primate, aging, microbiome, periodontitis, transcriptome
INTRODUCTION
Periodontal lesions and the associated hard and soft tissue
destruction of the periodontium represent the outcomes of
a chronic inflammatory response to the burden of the
microbiome at affected sites. This disease is accentuated with
age, likely reflecting a combination of general tissue health and
remodeling capabilities, long-term environmental and epigenetic
effects on tissue homeostasis and the oral microbiome, and
immunosenescent changes in the host response profile [1].
This dysbiotic microbiome displays an altered presence and an
abundance of microbial members, selected microorganisms that
appear to directly facilitate changes in the local environment
enhancing a more pathogenic microbiome, and altered gene
expression profiles of normal commensal bacteria that can
contribute to altering the host-inflammatory response [2–5].
Approaches to lessen this microbial burden through both
mechanical and chemical strategies generally show a high
frequency of positive responses across the population in
decreasing the continuation of these lesions [6–8]. Substantial
literature regarding details of the human microbiome and
different arrays of host responses in the juxtaposed tissues
and gingival crevicular fluid exists, attempting to establish
relationships between the microbiome component bacteria
and/or complexes of these bacteria that dysregulate the host
responses and likely drive the destructive inflammation [9–13].
Nevertheless, a challenge with the investigations of naturally
occurring periodontitis in humans is that the biology of
the disease sites is only studied at the time of clinically
detected lesions, using somewhat crude observational tools
for inflammation and tissue destruction. As such, we have
employed a non-human primate model of naturally occurring
and experimental ligature-induced periodontitis for decades. The
disease has been shown to affect a wide array of non-human
primate species that demonstrate clinical, microbiological, and
immunological features similar to human disease [14–16]; exhibit
both age and sex differences similar to humans [17, 18]; can be
altered by mechanical, chemical, and vaccination interventions
[19–23]; and enable detailed studies of clinical resolution
of periodontal lesions. We have recently reported on gene
expression profiles in gingival tissues that enable discrimination
of health, disease kinetics, and resolution of the lesions [24].
Within this array of differentially expressed genes, we identified
members of the chemokine and cytokine families, and cell
receptors that contributed to the phase assignment.
This analysis examined gingival tissue responses and
microbiome features in non-human primates of different
ages. The interrogation of the dataset focused on a wide
array of chemokines, cytokines, chemokine and cytokine
receptors, and genes related to inflammatory lipid mediator
production and control. Additionally, the data enable us to
explore the relationship of specific microbes and complexes that
appear to be more directly linked to the altered expression of




Rhesus monkeys (Macaca mulatta) (n = 36; 17 male, 19 female)
housed at the Caribbean Primate Research Center at Sabana Seca,
Puerto Rico, were examined for periodontal health [18, 25, 26]
and were used to determine the results from a ligature-induced
periodontitis model. Young (≤3 years), adolescent (3–7 years),
adult (12–16 years), and aged (18–23 years) were used in the
study with nine animals/group. As an estimate, 1 monkey year
approximates 3.5 human years; thus, the groups represented
human subjects about 6–9 yo, 11–25 yo, 42–56 yo, 63–82 yo.
The non-human primates were fed a 20% protein, 5% fat, and
10% fiber commercial monkey diet (diet 8773, Teklad NIB
primate diet modified: Harlan Teklad, Madison, WI). The diet
was supplemented with fruits and vegetables, and water was
provided ad libitum in an enclosed corral setting.
As we have reported previously, the protocol was approved by
the Institutional Animal Care and Use Committees (IACUC) of
the University of Puerto Rico and the University of Kentucky,
and a ligature disease model was utilized [27]. The clinical
examination included probing pocket depth (PPD) and bleeding
on probing (BOP; 0–5 scale) [28]. Periodontal health was
defined by mean PPD ≤ 3.0mm and mean BOP ≤ 1 (0–
5 scale) in a full mouth examination excluding 3rd molars
and canines [27]. Ligature-induced periodontal disease was
initiated, as we have previously reported [27], and gingival
and subgingival plaque samples were taken at 0.5, 1, and 3
months (initiation/progression), and 2 months after the removal
of ligatures and local factors (resolution). Determination of
periodontal disease at the sampled site was documented by
assessment of the presence of BOP and PPD of >4mm, as
we have described previously [26]. Changes in these clinical
measures of BOP and PPD in health, during disease initiation
and progression, and resolution in these age groups have been
described previously [24]. Briefly, all animals demonstrated
significant increases in BOPwithin 0.5 months (0.6± 0.1 to 3.8±
0.1; mean± SEM), with somewhat elevated levels in the younger
age groups. PPD increases were noted in all animals across all age
groups with peak disease at 1–3 months. However, in both young
and adolescent animals, the PPD measures for the rate of change
and peak levels of the disease were less than in the adult and the
aged group (young/adolescent: 1.4± 0.1 to 3.9± 0.2; adult/aged:
2.7± 0.1 to 5.3± 0.2). The clinical resolution of the sites occurred
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over 2 months, resulting only from the removal of the ligatures.
At resolution, both BOP and PPD measures decreased across all
age groups, albeit generally remaining above measures for the
baseline, healthy tissues.
Microbiome Analysis
Subgingival bacterial samples were obtained from the 36 animals
by a curette and analyzed using a MiSeq instrument [29, 30]
for the total composition of the microbiome from each sample
[31, 32]. Sequences were clustered into phylotypes based on
their sequence similarity, and these binned phylotypes were
assigned to their respective taxonomic classification using the
Human Oral Microbiome Database (HOMD V13) (http://www.
homd.org/index.php?name=seqDownload&file&type=R), as we
have described previously [29]. Raw data were deposited
at the NIH NCBI (BioProject ID PRJNA516659). Statistical
differences of bacterial OTUs were determined with a t-test
(p < 0.05). Correlations of OTUs within the oral microbiome
were determined using a Pearson correlation coefficient analysis
(p < 0.05). Correlations between the microbiome components
and the gingival gene expression were determined only for
matching samples derived from the same tooth in each of the
animals. Matching samples with sufficient microbiome signals
were compared for 46 samples in adults and 25 samples from
the young group obtained at health and throughout the ligature
model. As we have reported previously [29], of up to 394 OTUs
identified in the non-human primate oral samples, the targeted
OTU selection for this study was 58 for the adult/aged samples
in which the relative abundance of these OTUs encompassed 74–
82% of the signal and 49 OTUs in the young/adolescent samples
covering 77–86% across the samples.
Gingival Tissue Sample Collection and
mRNA Analysis
Ligated teeth included the 1st premolar and 1st and 2nd molars
in each of the four quadrants. Gingival tissue samples from
healthy, diseased, and resolved sites were surgically collected
using a standard gingivectomy technique (e.g., crevicular incision
followed by an interdental incision at the base of the papillae),
providing a gingival sample from each animal at each time point,
and total RNA was extracted for microarray analysis [26]. Each
animal provided a gingival tissue sample at baseline, during the
three disease times, and at resolution. All of these were obtained
from distinct unique sites at each time point. The analytic
hybridization was to the GeneChip R© Rhesus Gene 1.0 ST Array
(Affymetrix, Santa Clara, CA, USA) for the ligature-induced
periodontitis model, similar to methods we have described
previously [25, 26, 33–35].
Data Analysis
Chemokine (n = 41), cytokine (n = 45), chemokine receptors
(n = 21), cytokine receptors (n = 37), and lipid mediator (n =
31) genes were targeted in the analysis (Supplementary Table 1).
Beyond the specific Affymetrix probe annotation provided by the
company, we annotated within the GeneChip R© Rhesus Gene 1.0
ST Array additional probes for the host genes in this microarray.
These included unannotated probes, whereby the nucleotide
base sequence (https://www.affymetrix.com/analysis/index.affx#
1_2) for each probe ID was subjected to a Blast (https://blast.ncbi.
nlm.nih.gov/Blast.cgi) query that identified the M. mulatta gene
ID with the greatest percent identified for the specific sequence.
We selected the most targeted gene ID that always showed >90%
identity for annotating the gene list for the analysis.
The expression intensities across the samples were estimated
using the robust multiarray average (RMA) algorithm with
probe-level quintile normalization, as implemented in the Partek
Genomics Suite software version 6.6 (Partek, St. Louis, MO).
The differential expression was initially compared using one-way
ANOVA across time points within an age group. For genes that
had significant mean differences, two-sample t-tests were used
to investigate differences comparing baseline healthy to disease
and resolution samples. Statistical significance was considered
by a p-value < 0.05 adjusted for the number of correlations
tested using a Benjamini-Hochberg procedure. The data have
been uploaded into GEO accession GSE180588 (https://www.
ncbi.nlm.nih.gov/gds).
Correlation analyses were determined using a Pearson
correlation coefficient with a p-value < 0.05 and adjusted
for the number of correlations tested. Gephi software was
used for generating a dual-circle layout representing significant
correlations (α = 0.01) between inflammatory mediator genes
and the microbiome OTUs. A parametric t-test (α = 0.05) was
used to identify the differentially expressed genes and bacteria at
0.5, 1, 3, and 5 months using baseline expression as the control.
Those that were differentially expressed, at least at one of the
time points, were identified and a principal component analysis
(PCA) was subsequently used to examine clustering of both age
groups of the animals across the different time points from their
normalized expression profiles.
RESULTS
Age Effects on Inflammatory Gene
Expression in Healthy Gingival Tissues
Figure 1 displays a comparison of the normalized counts for
gene expression in baseline healthy tissue samples from the
different age groups for those genes with significant differences
across the age groups. A rather limited repertoire of chemokine
genes varied across the age groups, with CXCL16, CXCL6,
CXCL8, CCL19, and CXCL13 being decreased in the young
and/or adolescent samples. In contrast, CXCL14, CXCL9, and
CXCL10 were increased in the adolescent and aged samples, and
CXCL11 only in the adolescent samples. Differential expression
was more pronounced with the chemokine receptor levels with
CXCR2/IL8RB, CXCR1, CCR6, and CCR1 all decreased in the
young and adolescent animals, and in addition CCR2 in only
the young samples. Generally, differential expression in the
aged samples was increased including CXCR2, CXCR4, CCR7,
ACKR1, and CXCR6. A very limited number of cytokines differed
in healthy samples across the age groups with lower levels
of IL36A, IL36G, and IL1A in young and adolescent animals
and elevated IL36A in the aged healthy tissues. The figure
also summarizes cytokine receptor expression. With this set
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FIGURE 1 | Comparison of normalized expression values for chemokine and chemokine receptor (A), cytokine and cytokine receptor (B), and lipid mediator (C)
genes in healthy gingival tissues across the age groups. Depicted are those genes in each category with a significant difference among the groups based on adjusted
ANOVA analysis (p < 0.05). The bars represent mean normalized expression values for each age group of nine animals. The bar and/or asterisk denote significant
difference from the adult group levels.
of inflammatory genes, specimens from young and adolescent
animals were quite similar to adult levels, except IL10RA that was
substantially decreased and IL13RA1 that was increased in the
young animals. Elevated levels of expression of IL10RB, IL22RA1,
and IL7R were the limited group of receptor genes that were
increased in the aged samples. The figure also displays variations
in genes related to the production and functional actions of
inflammatory lipid mediators. There were striking differences
in the expression of an array of these genes compared with
the adult levels that focused on young and adolescent gingival
tissues. Nine of these genes were decreased compared with adults
and nine additional ones were increased. Of particular note
were the significant increases in ALOXE3, ALOX12B, EPHX2,
and PTGER3 in the younger groups. Thus, an overview of
the differences in healthy tissues showed limited effects on the
genes for chemokine and cytokine effector molecules affected by
aging; however, more numerous effects were noted for receptors
for the chemokines and cytokines. In contrast, the gene family
associated with inflammatory lipids was substantively different in
the young and adolescent groups, suggesting the potential for a
very different milieu of these mediators even in healthy tissues.
Supplementary Figures 1A–C provides the overall expression
profile for all the inflammatory genes organized based upon the
expression level in the adult samples.
Age Effects on Inflammatory Gene
Expression and Progressing Periodontitis
Of particular interest were changes that could occur in the array
of inflammatory mediator genes during initiation, progression,
and resolution of experimental periodontitis using non-human
primates across the lifespan. Figure 2A demonstrates chemokine
gene changes with disease affected by age. In the young
and adolescent animals, similar chemokines were affected by
CXCL1, CXCL2, CXCL6, CXCL8, CXCL13, CXCL14, CCL3, and
CCL18 all increased with disease initiation and progression.
In contrast, CXCL9, CXCL10, and CXCL11 were all decreased
in the adolescent samples. Few of these remained elevated in
the resolution samples. Generally, this profile of genes was also
differentially expressed in samples from adults and aged animals.
Additionally, CCL11, CCL20, and CXCL4L1 were elevated in
the adults and aged samples. Also, with these inflammatory
molecules, the greatest increase was observed in the disease
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FIGURE 2 | Continued.
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FIGURE 2 | Continued.
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FIGURE 2 | Fold-changes in chemokine (A), chemokine receptor (B), cytokine (C), cytokine receptor (D), and lipid mediator (E) genes comparing disease time point,
i.e., 0.5, 1, 3 months, and resolution, i.e., 5-month, samples to baseline levels in each age group (nine animals/group). Genes in each category are presented with
differential expression of ≥1.5 above or below the baseline. The bars denote mean differential expression at each timepoint and the bars and/or asterisks denote
significant difference at p < 0.05 (t test). The purple boxes highlight the genes that overlap in differential expression across the age groups.
initiation samples, with CXCL8 decreasing at resolution in all
but the young animals. Figure 2B shows the changes occurring
in chemokine receptors with the disease. In this case, there was
a commonality across all age groups with CCR1, CXCR1, and
ACKR1 being increased. As with the chemokines these changes
were most greatly affected with disease initiation. Cytokine
response profiles (Figure 2C) showed elevations in IL1B, IL36B,
IL24, and IL33 in all age groups. While IL1B was primarily
increased with disease initiation, IL33 was elevated throughout
the disease and in resolution samples, and IL24 only at disease
initiation. In contrast, IL36 cytokines were all decreased with
disease, and also IL22 in young and adult animals. IL18RAP and
IL22RA2 cytokine receptors were elevated across all age groups
with the former primarily at disease initiation and the latter
throughout the disease and even resolution samples (Figure 2D).
Additionally, IL7R was increased in young and adult animals
at all disease time points. Within the lipid mediator gene
portfolio, CMKLR1 was increased in all age groups, with EPHX4
elevated except in aged samples. ALOX12B, ALOXE3, and
HPDG/PDGHwere decreased throughout disease and resolution
in all age groups. In contrast, PTGS2 was elevated in only
the adult and aged animals and was decreased in the younger
groups (Figure 2E).
Oral Microbiome and Inflammatory Gene
Expression in Health and Disease
To have sufficient analytic power to estimate correlations of
the various inflammatory genes with the overall microbiome
characteristics from matched sites, sample results from the
adult and aged groups were combined (AD/AG), as were the
sample results from the young and adolescent animals (Y/ADO).
Figure 3 summarizes the variations in the oral microbiomes
of the different age groups grouped into the primary bacterial
families that generally comprised 77–86% of the reads in the
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FIGURE 3 | Stacked bar charts display a relative abundance of microbial families within the oral microbiome samples from the young/adolescent (Y/ADO; n = 25
samples) and adult/aged (AD/AG; n = 46) groups. Abundance levels are grouped in high abundance families (TOP) and low abundance families (BOTTOM) with in the
AD/AG samples.
Y/ADO samples and 74–82% in the AD/AG groups. The results
demonstrated somewhat limited differences in the major families
in the AD/AG group from health to disease and resolution;
however, alterations in the relative abundance of unclassified
bacteria, Bacillales, and Lactobacillales were observed with the
disease in this group. This contrasted with clear differences
in the major families in samples from Y/ADO animals. The
data showed a decrease in Pasteurellales and increases in
Bacteroidales, Fusobacteriales, Synergistales, and Veillonellales
with the disease. Also noted was the substantial increases
in the relative abundance of Bacillales, Lactobacillales, and
Pseudomonadales in the Y/ADO baseline (healthy) samples
compared with the older group. Decreased Lactobacillales and
increases in Clostridiales and Flavobacteriales were observed in
disease in the younger groups.
Initial correlations of inflammatory mediators and the
microbiome were explored with measures of microbiome
diversity and richness by determining the Shannon diversity
index [36], inverse Simpson value (https://mothur.org/
wiki/invsimpson/), Chao1 [37], ACE [38], and each of the
inflammatory mediator genes. Table 1 depicts the frequency
of these correlations with the various groups of inflammatory
genes. The relationships with the chemokine genes were
primarily observed with the diversity indices focused on richness
and evenness of species (Shannon, inverse Simpson), were
skewed toward negative correlations, and primarily occurred in
healthy samples from both the age groups. A similar skewing
toward negative correlations in both age groups was seen
with the cytokine and cytokine receptor genes, although these
relationships were only noted in the Y/ADO group healthy
samples for the chemokine receptor and lipid mediator genes.
Generally, the values for the disease samples across all the
gene families were less remarkable with any of these overall
microbiome measures. Finally, the ACE measure is an abundant
description of coverage that estimates species richness. This
measure showed extensive positive correlations with healthy
samples from the Y/ADO group. Thus, there appeared to be a
more robust relationship between the overall microbiome and
these inflammatory mediator transcript levels under conditions
of clinical periodontal health; however, with the disease,
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TABLE 1 | Distribution of significant correlations of genes for various inflammatory mediator families and the individual measures of the overall microbiome features in the
different age groups of animals. The values denote the number of positive (Pos) or negative (Neg) correlations.
Genes Diversity Index AD/AG AD/AG Y/ADO Y/ADO
Health Disease Health Disease
Pos Neg Pos Neg Pos Neg Pos Neg
Chemokines Inverse Simpson 1 6 1 2 1 9 0 0
Shannon 4 4 1 3 1 8 0 0
Chao1 0 3 0 2 0 7 0 1
Ace 0 3 0 1 9 2 1 1
Chemokine Receptors Inverse Simpson 1 3 0 1 0 7 0 1
Shannon 0 0 0 1 1 8 0 1
Chao1 0 4 0 1 1 1 0 1
Ace 0 4 0 1 7 1 0 3
Cytokines Inverse Simpson 4 4 0 3 2 6 0 0
Shannon 4 4 0 5 2 8 0 2
Chao1 2 0 0 3 2 1 0 0
Ace 0 1 0 3 11 5 1 1
Cytokine Receptors Inverse Simpson 2 5 0 0 0 6 0 0
Shannon 0 4 2 0 0 7 1 0
Chao1 4 2 1 0 2 3 1 0
Ace 4 1 1 0 8 0 0 2
Lipid Mediators Inverse Simpson 1 0 0 0 1 2 0 0
Shannon 1 0 1 1 0 5 0 0
Chao1 2 1 0 0 3 1 0 0
Ace 1 0 0 0 5 2 0 0
these relationships appear to disappear, and the host–microbe
interactions become more related to individual or complexes of
the microbes within the overall microbiome.
Oral Microbiome Components and
Inflammatory Gene Expression in Health
and Disease
Figures 4A,B summarizes the frequency of significant
correlations between individual microbiome operational
taxonomic units (OTUs) and host chemokine, chemokine
receptor, cytokine, cytokine receptor, and lipid mediator
genes. Figure 4A depicts the distribution of significant
positive or negative gene correlations in healthy samples
from the Y/ADO animals. Of interest was a select
group of bacteria including, Pasteurallaceae_unclassified,
Bacteroidetes_unclassified, Streptococcus sp. HMT 058,
and Porphyromonadaceae_unclassified, all showing a high
frequency of positive correlations with a range of the
inflammatory mediator genes. In contrast, Bacteria_unclassified,
Selenomonas_unclassified, and P. gingivalis HMT 619
demonstrated a similar broad relationship with the inflammatory
mediator genes, but with a negative correlation. Figure 4B
demonstrates a very different profile of correlations in disease
samples from the Y/ADO animals. Negative correlations of
individual OTUs with any of the groups of inflammatory
genes were quite limited in this age group. While not at the
same frequency levels as in health, Treponema_unclassified,
Bacteroidetes_unclassified, and Prevotella sp. HMT 304 and 313
showed positive correlations with the inflammatory mediators,
with some difference in the subset of mediators, mostly related
to these OTU levels.
Similar correlations with healthy samples from the AD/AG
group are presented in Figure 4C. A large number of the OTUs
demonstrated positive or negative correlations with an array
of inflammatory mediator genes. In particular, Fretibacterium
sp. HMT 361, Prevotella sp. HMT 526, F. fastidiosum HMT
363, Eubacerium infirmum 105, and Treponema sp. HMT 246
showed a high prevalence of significant positive correlations
with some differences in the specific categories of inflammatory
mediators represented by these correlations. As was noted with
the Y/ADO samples, a different set of OTUs was negatively
correlated with panels of the inflammatory mediator genes
and included Bacteria_unclassified, Pasteurellaceae_unclassified,
Chloroflexi_{G-1] sp. HMT 439, Veillonellaceae_[G-1] sp. HMT
155, and P. piscolens HMT 357. The prevalence of positive
or negative correlations in the AD/AG samples during disease
was more limited across the OTUs, with some showing a clear
predisposition for these relationships (Figure 4D). An elevated
frequency of significant positive correlations was observed with
Fusobacterium_unclassified, Fretibacterium sp. HMT 361, S.
sputigena HMT 151, P. gingivalis HMT 619, P. enoeca HMT
600, T. maltophilum HMT 664, and F. fastidiosum HMT 363.
This contrasted with the negatively correlated OTUs that were
dominated by Bacteroidetes_unclassified, P. endodontalis HMT
273, and P. piscolens HTM 357. The principal features of
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FIGURE 4 | Continued.
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FIGURE 4 | Stacked bars denoted the frequency of genes for the five families of inflammatory mediator genes (CH, chemokines; CHR, chemokine receptors; CY,
cytokines; CYR, cytokine receptors; LI, lipid mediators) that correlated significantly with a relative abundance of the individual microbiome components. Summary of
results for both positive and negative correlations in healthy (A) or diseased (B) gingival samples from a pooled group of younger animals and in healthy (C) or
diseased (D) gingival samples from a pooled group of older animals.
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FIGURE 5 | Continued.
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FIGURE 5 | Graphical representation of dominant interactions between microbiome members and chemokine (A), chemokine receptor (B), cytokine (C), cytokine
receptor (D), and lipid mediator (E) genes in the pooled younger (Y/ADO) and older (AD/AG) group of animals. Magenta lines denote positive correlations and blue
denote negative correlations. The thickness of the connections to the nodes signifies the frequency of the interactions between two nodes.
these relationships in both age groups were clear differences
in the individual bacteria related to inflammatory mediator
gene expression, and also some overlap in the OTUs detected
in the young and older age group. Another observation was
that although some of these bacteria appeared to show a
broad relationship to the array of inflammatory mediator genes,
individual bacteria clearly had a predilection for specific groups
of chemokines/cytokines, their receptors, or lipid mediators that
was most prominent in the older age group.
Microbial Complexes and Inflammatory
Gene Expression in Aging
An important concept of the oral microbiome homeostasis
or dysbiosis in periodontitis is that the microorganisms
demonstrate ecological relationships that reflect cognate
interactions, nutritional cooperation or competition, and
potential virulence determinants that modify the local
microenvironment. Thus, we examined the features of the
oral microbiomes in the younger and older age groups focusing
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FIGURE 6 | Principal components analysis combining filtered gene expression (p < 0.05) and microbiome relative abundance levels in younger (Y/ADO) and older
(AD/AG) animals. Each point denotes one specimen at the different time points (BL, health; 0.5, initiation; 1, early progression; 3, late progression; 5, resolution). The
triangles signify the mean values for all the samples within the particular time point.
on identifying microbes that demonstrate similar patterns of
interactions to the array of inflammatory mediators in tissues
from juxtaposed sites. Figures 5A–E summarizes these results
for the AD/AG and Y/ADO groups for each of the subsets of
inflammatory mediator genes. The pattern of these interactions
in the AD/AG samples showed strong positive relationships
between an array of the bacteria and the chemokines (Figure 5A),
represented strongly by Fusobacterium_unclassified and P.
gingivalis HMT619. More limited negative correlations were
observed. In contrast in the Y/ADO samples, the majority of
the interactions were negative correlations. The interaction
patterns with the chemokine receptors also demonstrated a
dramatic difference with dominant positive correlations in
the AD/AG and negative correlations in the Y/ADO samples
(Figure 5B). In the AD/AG samples, fewer bacteria were
represented, albeit, Fusobacterium_unclassified, P. gingivalis
HMT619, and P. enoeca HMT600 were major representatives.
In the Y/ADO samples, the pattern suggested a predilection for
selected receptors (e.g., CXCR4, CXCR5, ACKR1, CMKLR1,
and CCR10) to be associated with multiple bacteria. In both
the AD/AG and Y/ADO samples multiple bacterial OTUs were
related to the cytokines in the gingival tissues (Figure 5C). As
with the other inflammatory genes types, the majority of the
correlations were positive in the AD/AG samples. In the Y/ADO
samples, robust negative interactions between an array of the
cytokines and M. catarrhalis HMT833, Haemophilus sp. 035
G. morbillorum HMT046, and Pasturellaceae_unclassified were
seen. Figure 5D showed striking differences between the bacteria
and the cytokine receptors between the age groups. A large
number of OTUs showed rather limited positive interactions
with individual receptors in the AD/AG samples. In contrast,
a more limited group of bacteria were broadly correlated
with these receptors in the Y/ADO samples. In particular,
IL10RB, IL17RC, IL22RA2, TNFRSR1B, IL11RA, IL20RB,
IL27RA, IL4R, and IL1R1 showed extensive interactions with
M. catarrhalis HMT833, Haemophilus sp. 035 G. morbillorum
HMT046, Pasturellaceae_unclassified, and Prevotella sp.
HMT317, similar to the patterns with the cytokine genes.
Finally, Figure 5E summarizes the interactions of the OTUs
with the lipid mediator genes. As was noted with the other
inflammatory genes, positive correlations dominated in the
AD/AG samples. Fusobacterium_unclassified, P. gingivalis
HMT619, P. enoeca HMT600, and Leptotrichia sp. HMT223
demonstrated the most robust interaction across this gene family
including ALOX5AP, PTGS2, PTGR1, PLA2G2A, and ALOXE3.
A more limited group of bacteria showed interactions in the
Y/ADO samples, with a mixture of strong positive and negative
correlations with EPHX4, ALOXE3, LTA4H, PDGH, EPHX3,
ALOX5, and ALOX12B. As with other inflammatory genes in
this age group, the related OTUs highlighted M. catarrhalis
HMT833, Haemophilus sp. 035 G. morbillorum HMT046,
and Pasturellaceae_unclassified.
Finally, we examined the capacity of the microbiomes and
inflammatory mediator panel to discriminate health, disease
initiation/progression, and resolution in the two age groups of
animals. Figure 6 displays the results and demonstrates that a
clear separation with nearly 50% of the variance in the data
was accounted for by the first two principal components. In
particular, the baseline (health) and the resolution samples were
distinct. Additionally, with these markers, the disease initiation
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samples (0.5 months) also showed some differential composition;
however, the specimens during disease progression (1 and 3
months) were not particularly distinct based upon inflammatory
mediators and themicrobiomemeasures. In contrast, in the older
group 41% of the variance in the data was accounted by the
first two principal components, with the baseline values distinct
from all the disease timepoints, and the disease initiation samples
(0.5 months) being unique. Minimal differences were seen in
the disease progression samples. An additional observation was
that while the resolution values were somewhat distinct from the
other time points, some of these samples appeared similar to the
healthy specimens, and a second subset appeared more closely
aligned with the late disease progression values.
DISCUSSION
Clear evidence is available regarding the initiation and
development of the complex microbiome in the oral cavity.
Existing data have demonstrated unique features of the
microbiome in different niches in the oral cavity [3, 39, 40],
periodontitis vs. healthy periodontium in adults demonstrating
the effect of smoking and diabetes on the microbiome [2, 5, 41–
45], progressing vs. non-progressing periodontal sites [46–48],
and distribution of the large array of species across human
populations [5, 49]. Chronic periodontal infections provide
a very different “face” to the host with regards to controlling
these bacteria. Nevertheless, this dynamic host–bacterial
environment has evolved to help sustain a protective commensal
microbial ecology, while minimizing the ability of opportunistic
pathogens to emerge within these established biofilms [50, 51].
As importantly, current concepts of the transition of the ecology
from health to disease now emphasize features that propel
changes in the balance of microbes, resulting in a “dysbiosis”
that can trigger a disease process [52]. It still remains ill-defined
how this dysbiosis is created, and whether this is primarily
being driven by the emergence of pathogenic bacteria in the
subgingival ecology and/or stimulating a dysregulated host
innate and inflammatory response that is modulated by genetic
and epigenetic predisposition, as well as patient-modifiable
factors including smoking, diet, diabetes, stress, etc. [52].
An additional critical component in this environment is clear
evidence of the induction of features of both acute and chronic
inflammation with the transition in themicrobiome and health to
disease. A wide array of studies have documented in oral tissues
and fluids numerous host innate and inflammatory mediators
and cells that differentiate health from disease in humans
[9, 53, 54]. However, these data are generally derived from
cross-sectional point-in-time studies that demonstrate significant
differences. Recognizing the episodic nature of periodontal
lesions with exacerbations and remissions suggests a dynamic
process of transition from health to disease initiation, followed
by disease progression, and eventually lesion resolution. We have
previously identified an array of genes that form a profile of
responses coincident with these various phases using a non-
human primate of ligature-induced periodontitis [55]. Although
the patterns of genes identified were derived from a range of
biologic pathways, there was a clear representation of innate
immune and inflammatory genes. However, somewhat lacking
from oral sciences knowledge is the role that the members of the
acquired microbiome play in the portfolio of these responses in
the oral cavity.
This study focused on a large array of chemokine, chemokine
receptor, cytokine, cytokine receptor, and lipid mediator
genes in the gingival transcriptome related to periodontitis
and modified by age. Existing data stipulate that an altered
microbiome drives a dysregulation of the host response resulting
in the collateral damage of the periodontal tissues via the
actions of a wide array of host biomolecules. However, the
findings from human studies do not provide a robust kinetic
analysis of the detailed temporal changes in the microbiome
and host responses that likely occur in days, whereas human
studies have been limited to comparisons over multiple-month
intervals [56]. Thus, the true dynamic interactions between
members of the oral microbiome and the varied host response
components that maintain homeostasis or enable a disease
process remain somewhat enigmatic. The broader results
from this study demonstrate significant interactions between
individual members and complexes of oral bacteria with
somewhat unique aspects of the inflammatory response system.
The non-human primate microbiomes showed approximately
307-394 OTUs that could be detected in at least one sample
across the animals [29]. However, we identified that 58 OTUs
covered 80–82% of the total OTU reads in the AD/AG samples,
and 49 OTUs covered 87–90% of the reads in the Y/ADO
samples. Within this pathogenesis model of periodontitis, we
observed 15 OTUs with strong positive correlations across
multiple subsets of the inflammatory response mediators
in the AD/AG animals. This included Capnocytophaga,
Desulfovibrio, Filifactor, Fusobacteria, Leptotrichia, Prevotella,
Selenomonas, Pyramidobacter, Treponema, and Veillonella.
A major difference was noted in this comparison with the
samples from the Y/ADO samples, where 12 OTUs showed
robust negative interactions with an array of inflammatory
mediators represented by Bacteroides, Fretibacterium, Gemella,
Haemophilus, Moraxella, Pasteurella, Prevotella, Pyramidobacter,
Selenomonas, and Veillonella. Therefore, in this model there
appears to be some specificity to the microbial taxa most
specifically related to the regulation of inflammatory responses.
Additional studies will be required to drill down more deeply
into the capabilities of individual species, as well as the temporal
nature of these interactions.
The overall expression of the chemokines/cytokines
and chemokine/cytokine receptors was rather similar in
healthy gingival tissues from young to aged animals. This
is consistent with an important homeostatic regulation
of the array of local gingival inflammatory responses to
the septic oral environment throughout the lifespan in a
healthy periodontium. However, gene expression profiles
for the lipid mediators differed substantially with younger
specimens showing decreases in genes related to the synthesis of
inflammatory prostaglandins and leukotrienes, as well as effects
on prostaglandin inactivation and endogenous resolving lipids.
Increased expression levels of ALOXA3, ALOX12B, PTGR2,
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PTGER3, and EPHX2 are associated with metabolism and
cellular receptors for prostaglandins and enzymes contributing
to barrier functions of the epithelium. As such, it appears
that an array of components of the pathway regulating the
inflammatory lipids are expressed differently in young vs. older
samples and may relate to the characteristics of periodontal
inflammation generally unrelated to tissue destruction in young
individuals [57, 58].
The profiles of altered chemokines and chemokine receptors
with disease initiation and progression were also generally
similar across the age groups. In particular CCL18 (macrophage
inflammatory protein 4), CXCL6 (granulocyte chemotactic
protein 2), CXCL8 (IL-8), and CXCL13 (B cell-attracting
chemokine 1) were elevated and suggest a broad change in the
milieu-attractedmultiple inflammatory cell types into the lesions.
In contrast, CXCL10 (IP-10) and CXCL11 (I-TAC) levels were
decreased in young, adolescent, and aged animals with disease
progression potentially reflecting altered T cell communication
in the developing lesions. A similar outcome was noted with the
chemokine receptors, with CCR1 (MIP-1α receptor) and CXCR1
(IL-8 receptor) uniquely increased in all age groups throughout
the disease, potentially altering local interactions of resident and
inflammatory cells during disease.
Examination of cytokine gene levels showed that IL1B,
IL20 (proinflammatory and epithelial function), IL24 (MDA7;
member of IL-10 family), and IL33 (member of IL-1 family,
signals through IL1RL1; acts on Th2 cells) were increased in all
age groups and IL6 only in adults with the disease. Interestingly,
IL1B was decreased in the adolescent, adult, and aged animals
late in the disease and in lesion resolved tissues. Conversely,
IL36B (IL1F8), IL36G (IL1F9), and IL36RN were substantially
decreased in the adult and aged animals, and only IL36B was
decreased in young and adolescent samples. IL36B and IL36G
signal through IL1RL2 receptor and are stimulated in epithelial
cells by various inflammatory cytokines as part of the epithelial
barrier protection. IL36RN (IL36 receptor antagonist) inhibits
the activities of all the members of the IL36 cytokine family
and is also considered a part of the epithelial barrier protection.
Few cytokine receptor genes were increased in the various age
groups. However, IL18RAP, an accessory subunit for the IL-18
proinflammatory receptor, IL22RA2 (inhibits IL22 activity), and
IL7R that have a critical role in V(D)J recombination events were
increased primarily with disease initiation.
Differences noted in the lipid mediator gene expression
in healthy gingiva were also seen in the specimens during
disease initiation and progression. ALOX12B, HPGD, PTGS2,
and ALOXE3 were all decreased across all age groups and even
in resolution samples. As noted these gene products are critical
components of the production and regulation of prostaglandins
and leukotrienes in inflamed tissues, supporting a contribution to
the changes in the local environment following lesion induction.
The abundance of various OTUs in the oral microbiome
in health and during disease was also evaluated related to
this portfolio of inflammatory genes in the juxtaposed gingival
tissues. Specific OTUs of genera and species of oral bacteria
were significantly positively or negatively correlated with the
inflammatory genes. This was particularly evident in samples
from healthy periodontal sites in both the younger and the
older animals. Of interest was that the OTUs were mutually
exclusive in either positive or negative correlations. Moreover,
the individual OTUs showed some specificity regarding the
particular family of inflammatory genes dominating in these
correlations. Additionally, the dominant OTUs with these
correlations were virtually unique between the younger and
older specimens. Each of these features provides evidence of
a more direct linkage between selected individual members
of the oral microbiome and characteristics of the array of
inflammatory mediator responses occurring in the gingival
tissues. Substantial work has been done in attempting to identify
specific components on a small set of oral bacteria that would
likely contribute to changes in inflammatory responses in the
oral cavity. These include more classic factors such as LPS,
fimbriae, outer membrane proteins, exotoxins, proteases, etc.
[59–66]. However, generally these studies have focused on
microbes historically considered as likely periodontal pathogens.
These types of bacteria were identified within the list of
genera/species correlated with inflammatory gene expression in
this investigation, particularly in disease samples from adult/aged
animals and to a more limited extent in the young/adolescent
specimens. There also existed a range of bacteria that would be
considered members of the non-pathogenic commensal ecology
that strongly correlated with the families of inflammatory genes
in healthy samples from the young/adolescent animals. In
contrast, in healthy adult/aged samples, positively correlated
bacteria tended toward the species associated with pathogenic
biofilms, whereas the negatively correlated OTUs appeared more
consistent with the commensal species. Thus, the results support
a very dynamic interaction of the microbiome and gingival
tissue responses, as unique feature of this relationship in health
and during the disease process. A better understanding of the
features of the broadermicrobiomemembers could provide some
interesting insights into microbial components that may actually
trigger a response that enhances homeostasis through selective
inflammatory biomolecules and helps regulate the emergence of
more pathogenic species.
Multiparameter analyses demonstrated robust interactions
between specific members of the oral microbiome and detailed
features of the host responses within these five families of
inflammatory genes. Of note in these assessments was that the
bacteria involved in these interactions were quite distinct in the
samples from the younger vs. the older animals. Additionally,
the interactions in the adult/aged specimens were generally
positive correlations supporting the role of these particular
bacteria in contributing to the local inflammatory environment,
whereas the interactions in the young/adolescent samples were
skewed toward negative correlations. While examination of
the overall microbiome demonstrated extensive similarity in
the OTUs featured in the different age groups, our previous
results showed significant differences in the relative abundance
of various bacteria in the younger vs. older microbiomes in
both health and disease [24, 29, 67, 68]. These findings extend
the age differences by documenting significant distinctions in
the host responses to these microbes presenting the “same”
stimulatory features but resulting in divergent inflammatory gene
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expression profiles. The data were also explored to determine
the capacity of this set of host genes and the accompanying
microbiome to differentiate patterns for individual specimens
related to health, phases of the disease process, and with lesion
resolution. The results demonstrated clearly different features
for health and resolution in the young/adolescent groups. There
was less discrimination between the early and late progression
samples suggesting that these inflammatory markers were not
critical determinants during these phases of disease progression.
Similarly, differences in health and resolution samples were
seen in the adult/aged samples. However, of note was that the
resolution specimens appeared to show a subset that grouped
with the healthy baseline samples, and a second subset that
retained features more consistent with those of late disease
progression. This could infer that certain inflammatory and
microbiome features of particular lesion sites that appear
clinically resolved, and potentially related to individual animal
genetics, retain biologic features of the disease that increase
the risk for the future disease at these same sites, as has
been shown in humans with periodontitis [69–71]. Additionally,
limited separation was observed with early- and late-disease
progression samples in the adult/aged samples, supporting that
these inflammatory features may not be critical components
during this phase of the disease. Finally, the distribution of
the specimens obtained at disease initiation showed distinctive
features in both age groups of animals. As many of these host
response markers have been consistently identified in innate
immune and inflammatory responses, these findings support
a strong role for their expression in the earliest phases of
the periodontitis lesion across the lifespan. These data, in
conjunction with our previous studies in the non-human primate
disease model, support portfolios of genes and pathways that wax
and wane during the disease process closely linked to changes in
the bacterial complexes in themicrobiome and provide some new
insights into the underlying dynamics of the biological reactions
in health and disease.
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